A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever

Journal of Vector Borne Diseases

Volumn 49, Issue 2, 2012, Pages 105-110

  Bakir, Mehmet ^a   Engin, Aynur ^a   Gozel, Mustafa Gokhan ^a   Elaldi, Nazif ^a   Kilickap, Saadettin ^a   Cinar, Ziynet ^b  

^a Department of Infectious Diseases and Clinical Microbiology ^*  (Turkey)

^b CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; Mortality; Severity grading score

Indexed keywords

IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CRIMEAN CONGO HEMORRHAGIC FEVER; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEVERITY GRADING SCORE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL MEDICINE; FEVER; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84864382432     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ergonul O. Crimean-Congo hemorrhagic fever. Lancet Infect Dis 2006; 6: 203-14.
2. Scientific assessment report of the Crimean-Congo hemorrhagic fever (Kirim Kongo Kanamali Atesi Bilimsel Degerlendirme Raporu). Ankara, Turkey: The Turkish Medical Association Publications (Türk Tabipleri Birligi Yayinlari), [in Turkish] 2010. Available from: http://www.ttb.org.tr/kutuphane/kirim_kongo_rpr.pdf (last accessed on December 20, 2011).
3. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11(Suppl 4): S794-800.
4. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Scientific subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
5. Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct 2009; 39: 158-60.
6. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006; 12: 551-4.
7. Cevik MA, Erbay A, Bodur H, Gulderen E, Bastug A, Kubar A, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12: 374-9.
8. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H. Crimean-Congo hemorrhagic fever outbreak in middle Anatolia: a multicenter study of clinical features and outcome measures. J Med Microbiol 2005; 54: 385-9.
9. Onguru P, Dagdas S, Bodur H, Yilmaz M, Akinci E, Eren S, et al. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Clin Lab Anal 2010; 24: 163-6.
10. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol 2010; 47: 361-5.
11. Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EK, et al. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis 2010; 42: 516-21.
12. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006; 52: 207-15.